文献速递产科母胎医学

基于19-24周妊娠期先兆子痫风险的分层妊娠护理中的 contingent 筛查

Contingent screening in stratification of pregnancy care based on risk of pre-eclampsia at 19-24 weeks' gestation.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-09-01

这项前瞻性观察研究纳入37 886例单胎妊娠,于19-24周常规评估时,比较在母体因素、UtA-PI和MAP筛查基础上加用PlGF和sFlt-1对先兆子痫筛查性能的提升。研究发现,在固定风险截断值下,五联筛查检测率最高、筛查阳性率最低,且仅对约40%人群检测PlGF和sFlt-1的contingent筛查即可达到最大性能。

要点

  • 在19-24周,母体因素、UtA-PI和MAP联合筛查先兆子痫,加用PlGF和sFlt-1可提高性能。
  • 仅对约40%人群检测PlGF和sFlt-1的contingent筛查即可达到最大筛查性能。
  • 五联筛查在固定风险截断值下检测率最高且筛查阳性率最低。

核心结论

  • 在母体因素、UtA-PI和MAP筛查基础上,对约40%人群加测PlGF和sFlt-1可改善先兆子痫筛查性能。

研究设计与样本

  • 前瞻性观察研究,在英国两家产科医院纳入37 886例单胎妊娠,于19-24周进行常规评估。

主要发现

  • 在固定风险截断值下,母体因素、UtA-PI、MAP、PlGF和sFlt-1联合筛查的检测率最高且筛查阳性率最低。
  • 仅对约40%人群检测PlGF和sFlt-1的contingent筛查即可达到最大筛查性能。

关键数值与推荐

  • 在固定风险截断值下,五联筛查(母体因素、UtA-PI、MAP、PlGF、sFlt-1)检测率最高、筛查阳性率最低。
  • contingent筛查仅需对约40%人群测量PlGF和sFlt-1即可达到最大性能。

临床怎么用

  • 可考虑在19-24周先采用母体因素、UtA-PI和MAP进行初筛,仅对约40%人群加测PlGF和sFlt-1以优化先兆子痫风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the possibility of carrying out routine screening for pre-eclampsia (PE) with delivery at < 28, < 32, < 36 weeks' gestation by maternal factors, uterine artery pulsatility index (UtA-PI) and mean arterial pressure (MAP) in all pregnancies and reserving measurements of placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) for only a subgroup of the population. METHODS: This was a prospective observational study in two UK maternity hospitals involving women with singleton pregnancy attending for routine assessment at 19-24 weeks' gestation. The improvement in performance of screening for PE, at fixed risk cut-offs, by the addition of serum PlGF and sFlt-1 to screening by maternal factors, UtA-PI and MAP, was estimated. We examined a policy of contingent screening in which biochemical testing was reserved for only a subgroup of the population. The main outcome measures were the additional contribution of PlGF and sFlt-1 to the performance of screening for PE and the proportion of the population requiring measurement of PlGF and sFlt-1 for maximum performance of screening. RESULTS: The study population included 37 886 singleton pregnancies. At each risk cut-off, the highest detection rates for delivery with PE and the lowest screen-positive rates were achieved in screening with maternal factors, UtA-PI, MAP, PlGF and sFlt-1. The maximum performance by such screening was also achieved by contingent screening in which PlGF and sFlt-1 were measured in only about 40% of the population. CONCLUSION: The performance of screening for PE by a combination of maternal factors, UtA-PI and MAP is improved by measurement of PlGF and sFlt-1 in about 40% of the population. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Litwinska M, Litwinska E, Bouariu A, et al. Contingent screening in stratification of pregnancy care based on risk of pre-eclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol. 2021. PMID: 34309913. doi:10.1002/uog.23742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。